Tregs and GvHD prevention by extracorporeal photopheresis: observations from a clinical trial

被引：9
|
作者：
Roberto, Crocchiolo [1 ]
Clara, Cesana [1 ]
Debora, Girgenti [1 ]
Giambattista, Bertani [2 ]
Claudia, Barba [1 ]
Giuseppa, Liga [1 ]
Ursula, Ferri [1 ]
Lara, Crucitti [2 ]
Giovanni, Grillo [2 ]
Silvano, Rossini [1 ]
Roberto, Cairoli [2 ]
机构：
[1] ASST Grande Osped Metropolitano Niguarda, Serv Immunoematol & Med Trasfus, Piazza Osped Maggiore 3, I-20162 Milan, Italy
[2] ASST Grande Osped Metropolitano Niguarda, Ematol, Milan, Italy
来源：
EXPERIMENTAL HEMATOLOGY & ONCOLOGY | 2021年 / 10卷 / 01期
关键词：
Graft-versus-host disease; T regulatory cells; Extracorporeal photopheresis; Allogeneic hematopoietic stem cell transplantation;
D O I：
10.1186/s40164-021-00210-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The aim of the present study was to evaluate the circulating T regulatory cells (Tregs) in patients undergoing extracorporeal photopheresis (ECP) for the prevention of chronic graft-versus-host disease (GvHD) and to search for any correlation between Tregs counts and chronic GvHD occurrence. Among n = 12 patients with complete longitudinal data, the median cumulative values of absolute peripheral Tregs counts were 21.64 and 63.49 cells/mu L for patients who developed chronic GvHD and those who did not develop it, respectively (p = 0.05). The analysis of the median absolute counts of peripheral HLA-DR + Tregs provided similar results, showing that 20% (1 out of 5) and 100% (7 out of 7) of patients with HLA-DR + Tregs values of > 5 cells/mu L were in the GvHD and non-GvHD groups, respectively (p = 0.01). In conclusion, the present results support the involvement of Tregs in the prevention of chronic GvHD in patients receiving ECP and suggest Tregs count as a potential biomarker of ECP effectiveness. Future strategies are needed to enhance Tregs expansion and/or activity in conjunction with ECP for an effective chronic GvHD prevention.
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Extracorporeal photopheresis for treatment of GvHD after donor lymphocyte infusion
    Del Fante, C.
    Scudeller, L.
    Viarengo, G.
    Cervio, M.
    Castagna, L.
    Perotti, C.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S442 - S442
  • [32] Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD
    F L Dignan
    D Greenblatt
    M Cox
    J Cavenagh
    H Oakervee
    J F Apperley
    A K Fielding
    A Pagliuca
    G Mufti
    K Raj
    D I Marks
    P Amrolia
    A Peniket
    P Medd
    M N Potter
    B E Shaw
    J J Scarisbrick
    Bone Marrow Transplantation, 2012, 47 : 824 - 830
  • [33] Extracorporeal photopheresis for steroid refractory acute GvHD in children and adults
    Calore, E.
    Duce, R.
    Strada, P.
    Gualandi, F.
    Pillon, M.
    Van Lint, M. T.
    Lamparelli, T.
    Cesaro, S.
    Raiola, A. M.
    Dominietto, A.
    Di Grazia, C.
    Bregante, S.
    Buldini, B.
    Winzler, C.
    Varotto, S.
    Zia, S.
    Gazzola, M.
    Destro, R.
    Bacigalupo, A.
    Messina, C.
    Marson, P.
    Tison, T.
    Ruzzenenti, M. R.
    De Luigi, M. C.
    Cartier, P.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S139 - S139
  • [34] Extracorporeal photopheresis for the treatment of refractory acute and chronic GVHD in children
    Faraci, M
    Lanino, E
    Rivabella, L
    Martinengo, M
    Dallorso, S
    Miano, M
    Morreale, G
    Manzitti, C
    Scarso, L
    Dini, G
    BONE MARROW TRANSPLANTATION, 2001, 27 : S213 - S213
  • [35] EXTRACORPOREAL PHOTOPHERESIS FOR THE TREATMENT OF GVHD IN CHILDREN IN THE ERA OF TRANSPLANT FROM PARTIALLY MATCHED DONORS
    Maffeis, Marianna
    Soncini, Elena
    Baresi, Giulia
    Rossi, Stefano
    Gorio, Chiara
    Ferrari, Emilio
    Lanfranchi, Arnalda
    Porta, Fulvio
    BONE MARROW TRANSPLANTATION, 2024, 59 : 342 - 343
  • [36] Extracorporeal photopheresis (ECP) in children with refractory chronic GVHD: Feasibility and efficacy
    Browning, B
    Collins, J
    Thormann, K
    Duerst, R
    Kletzel, M
    Jacobson, D
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 110 - 111
  • [37] Biomarkers for Clinical Response of Extracorporeal Photopheresis
    Ni, Ming
    Wang, Lei
    Huckelhoven, Angela
    Sellner, Leopold
    Hoffmann, Jean-Marc
    Luft, Thomas
    Hegenbart, Ute
    Schonland, Stefan
    Kleist, Christian
    Sill, Martin
    Chen, Bao-an
    Wuchter, Patrick
    Eckstein, Volker
    Kruger, William Hermann
    Hilgendorf, Inken
    Nagler, Arnon
    Muller-Tidow, Carsten
    Ho, Anthony D.
    Dreger, Peter
    Schmitt, Michael
    Schmitt, Anita
    BLOOD, 2017, 130
  • [38] Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation
    Shaughnessy, P. J.
    Bolwell, B. J.
    van Besien, K.
    Mistrik, M.
    Grigg, A.
    Dodds, A.
    Prince, H. M.
    Durrant, S.
    Ilhan, O.
    Parenti, D.
    Gallo, J.
    Foss, F.
    Apperley, J.
    Zhang, M-J
    Horowitz, M. M.
    Abhyankar, S.
    BONE MARROW TRANSPLANTATION, 2010, 45 (06) : 1068 - 1076
  • [39] Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation
    P J Shaughnessy
    B J Bolwell
    K van Besien
    M Mistrik
    A Grigg
    A Dodds
    H M Prince
    S Durrant
    O Ilhan
    D Parenti
    J Gallo
    F Foss
    J Apperley
    M-J Zhang
    M M Horowitz
    S Abhyankar
    Bone Marrow Transplantation, 2010, 45 : 1068 - 1076
  • [40] Analysis of Clinical Outcome and Survival in Pediatric Patients Undergoing Extracorporeal Photopheresis for the Treatment of Steroid-refractory GVHD
    Gonzalez Vicent, Marta
    Ramirez, Manuel
    Sevilla, Julian
    Abad, Lorea
    Angel Diaz, Miguel
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2010, 32 (08) : 589 - 593
12345